Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Zenan Xu
Institutions:
Fifth Affiliated Hospital of Xinjiang Medical University,
Xinjiang Institute of Materia Medica,
Xinjiang University
Observed institutions:
Fifth Affiliated Hospital of Xinjiang Medical University,
Xinjiang Institute of Materia Medica,
Xinjiang University
ORCID:
0009-0001-4806-8261
Observed ORCID:
0009-0001-4806-8261
OpenAlex ID:
A5139023422
The Warburg effect and beyond: Glycolytic reprogramming in cancer progression and emerging therapeutic strategies
2026
·
Yuxuan Long
, Jianxiong Xu
, et al.
·
Biomedicine & Pharmacotherapy
·
3
GPX4 in the Tumor Microenvironment: Not Just Inhibiting Ferroptosis, but Immuno-Metabolic Regulation
2026
·
Xinzhe Li
, Manxuan Zhang
, et al.
·
Biomolecules
·
2
Beyond Structural Classification: A 4S+G Functional Framework for Non-Coding RNA Biology in Cancer and Its Therapeutic Implications
2026
·
Zenan Xu
, Manxuan Zhang
, et al.
·
Biomolecules
Transcriptional and epigenetic regulation of ferroptosis in cancer drug resistance: Mechanisms and targeted therapeutic opportunities
2026
·
Zenan Xu
, Manxuan Zhang
, et al.
·
Biochemical Pharmacology
Beyond Junk DNA: Emerging Roles of Non-Coding RNAs in Cancer and Therapeutic Innovation
2026
·
Li Qiu
, Zenan Xu
, et al.
·
Biomolecules
miR-145-5p Is Required for the Antitumor Activity of Strophanthus gratus-Derived Ouabain in Colorectal and Breast Cancer
2026
·
Jianxiong Xu
, Zhiming Lv
, et al.
·
Pharmaceuticals
Beyond Warburg: mitochondrial oxidative phosphorylation and redox adaptation as therapeutic frontiers in cancer
2026
·
Wenfang Li
, Zenan Xu
, et al.
·
SSRN Electronic Journal
Show more works
View as search
Works count:
7
Citation count:
5
H-index:
2
I10-index:
Year
Topic
Type